FDA approves new injectable drug to treat schizophrenia

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia.
Mental Health News From Medical News Today

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter